Lifetime Risk of Lung Cancer Death for Inhalation 239Pu

2017 ◽  
Vol 62 (1) ◽  
pp. 27-31 ◽  
Author(s):  
Василенко ◽  
E. Vasilenko ◽  
Ефимов ◽  
A. Efimov ◽  
Востротин ◽  
...  

Aim of the study: Assessment of reliability of radiation safety standards after inhalation intake of Pu-239. Material and methods: Using results of epidemiological study of lung cancer mortality in Mayak workers cohort and statistical data on all causes and lung cancer mortality in Russia the excess lifetime risk of lung cancer death was calculated. Results: Current radiation safety standards restrict annual intake of Pu-239 class “S” at 1300 Bq/year level. The annual limit of intake is calculated in a way that the level of committed effective dose in 50 years after intake should not exceed 20 mSv. At the same time radiation safety standards restrict the level of the excess lifetime risk of cancer death at the level of 0.05 (for category A personnel) and/or annual increment of excess lifetime risk at the level 0.001. The equivalent dose of alpha-particles to the lung after 50 years of inhalation intake of Pu class “S” when calculated according to DOSE-2008 model will be 7 Sv. Given the pattern of dose accumulation over time after this scenario of Pu class “S” inhalation intake we calculated excess relative risk of lung cancer death, lifetime excess risk of lung cancer death and annual increment of excess lifetime risk. In 50 years of exposure to inhalation intake of Pu-239 class “S” the excess lifetime risk of lung cancer death will be 0.08, i.e. will exceed the 0.05 limit provided in radiation safety standards. The annual increment of the lifetime risk will exceed limit of 0.001, provided by the radiation safety standards, at age 45 and older. These results demonstrate that the protection of personnel working with Pu-239 class “S” is insufficient in current radiation safety standards. One of the potential reasons is that lung contribution to total detriment for organism provided by ionizing radiation is averaged for all ages whereas for people of working age who contact to Pu at work this detriment doubles.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 1523-1523
Author(s):  
Hormuzd A. Katki ◽  
Stephanie A Kovalchik ◽  
Martin Tammemagi ◽  
Christine D. Berg ◽  
Neil Caporaso ◽  
...  

1523 Background: Low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20% in the National Lung Screening Trial (NLST). The efficacy of LDCT screening could be improved by targeting smokers at highest risk of lung cancer death, provided that the efficacy of LDCT screening increases with lung cancer mortality risk. Methods: We evaluated the efficacy of LDCT screening as compared to chest radiography in the NLST across groups defined by participants’ 5-year risk of lung cancer mortality at randomization, which was estimated using a validated prediction model. Across quintiles of 5-year lung cancer mortality risk [Q1: 0.15%-0.55%, Q2: 0.56%-0.84%, Q3: 0.85%-1.24%, Q4: 1.24%-2.0%, Q5: >2.0%], we estimated the number of participants with false positive screens, the number of prevented lung cancer deaths, and their ratio. Results: The number of prevented lung cancer deaths due to LDCT screening increased in tandem with lung cancer mortality risk (Q1=0.2, Q2=3.5, Q3=5.1, Q4=11.0, Q5=12.0 per 10,000 person-years; P-trend=0.01). The number of participants with false positive screens per lung cancer death prevented, a measure of screening efficiency, significantly decreased with increasing risk (Q1=1,648, Q2=181, Q3=147, Q4=64, Q5=65, P-trend<0.001). The 60% of participants at highest 5-year lung cancer mortality risk (0.85% or greater) accounted for 88% of LDCT-preventable lung cancer deaths and included only 64% of participants with a false positive screen. The 20% of participants at lowest lung cancer mortality risk (0.15%-0.55%) accounted for only 1% of LDCT-preventable lung cancer deaths. Conclusions: In the NLST, LDCT screening prevented the most lung cancer mortality among those at highest lung cancer mortality risk and prevented almost no mortality among those at lowest risk, providing empirical support for risk-based targeting of smokers to improve the efficacy of LDCT screening.


1968 ◽  
Vol 13 (10) ◽  
pp. 338-348
Author(s):  
A. J. Haddow

Cancer, responsible for about 1 death in 5 in Scotland, cost over £1 per head of population in 1965 and led to bed occupation of almost 2,000 bed years. Time lag (symptoms-doctor-hospital-treatment) is usuallv small. Age distribution is as in other European countries. Excluding accidents, cancer is the second most important cause of death in children. In relation to other countries Scotland's position is very poor and the lung cancer mortality in both sexes is the highest known. Lung cancer is the most important in males, breast cancer in females. Alimentary cancers come second in both sexes. In this century alimentary cancers increased till the thirties or forties and then declined. Cancers of pancreas, cervix uteri, ovary, prostate, kidney and bladder, together with leukaemia, have all increased. Cancer of the lung has increased elevenfold in women and fiftyfold in men. It now accounts for 9 to 12 per cent of all male deaths in cities and large towns


2021 ◽  
pp. 111372
Author(s):  
Alberto Ruano-Ravina ◽  
Leonor Varela Lema ◽  
Marta García Talavera ◽  
Montserrat García Gómez ◽  
Santiago González Muñoz ◽  
...  

1988 ◽  
Vol 41 (1) ◽  
pp. 75-82 ◽  
Author(s):  
Kathleen M. Stavraky ◽  
Allan P. Donner ◽  
Jean E. Kincade ◽  
Moira A. Stewart

Sign in / Sign up

Export Citation Format

Share Document